SCHEMBL6431290

SCHEMBL6431290

CCCOC(=O)C[C@H](N)C(=O)OCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NAAA Q02083 1/20 0.36
DGKA P23743 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HCAR2 Q8TDS4 1/20 0.35
LMNA P02545 1/20 0.33
HTR2C P28335 1/20 0.33
P2RY10 O00398 4/20 0.33
GPR34 Q9UPC5 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
ESR1 P03372 1/20 0.32
CHRM1 P11229 1/20 0.32
TSHR P16473 1/20 0.32
SLC6A2 P23975 1/20 0.32
KDR P35968 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6431283 1.00 MAPT (0.37) MAPTMAPK1NPSR1L3MBTL1NAAA
SCHEMBL16021211 0.92 ALOX15 (0.37) MAPTNAAADGKAALDH1A1HCAR2
SCHEMBL16021171 0.92 MGAM (0.41) MAPTMAPK1NPSR1L3MBTL1ALDH1A1
SCHEMBL1396441 0.88 NAAA (0.47) MAPTMAPK1NPSR1L3MBTL1NAAA
SCHEMBL14514324 0.88 NAAA (0.47) MAPTMAPK1NPSR1L3MBTL1NAAA
SCHEMBL8407943 0.88 NAAA (0.47) MAPTMAPK1NPSR1L3MBTL1NAAA
SCHEMBL25492404 0.88 SLC1A1 (0.35) MAPK1ALDH1A1HCAR2LMNAKDM4E
SCHEMBL16021170 0.87 ALDH1A1 (0.38) MAPTMAPK1NPSR1L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL3914767 0.86 NPSR1 (0.48) MAPTMAPK1NPSR1L3MBTL1NAAA
Hydrochloric Acid SCHEMBL3914765 0.86 NPSR1 (0.48) MAPTMAPK1NPSR1L3MBTL1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
US-20040220264-A1 Bioavailability and improved delivery of acidic pharmaceutical drugs YU RUEY J 2004-11-04 US claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
US-20030018100-A1 Inks with sulfonated polyester-amine resins XEROX CORPORATION. 2003-01-23 US claimed
US-6432601-B1 DRY TONER INK XEROX CORPORATION 2002-08-13 US claimed
US-6348561-B1 COPOLYMER FROM DIOL, DIACID, ALKALI SULFONATED DIACID AND AMINODIACID MONOMERS; TONERS, INKS, DISPERSANTS; HEAT AND COLD RESISTANCE; SHELF LIFE XEROX CORPORATION 2002-02-19 US claimed
CN-101495571-B Thermoplastic resin composition and molded body thereof MITSUI CHEMICALS, INC. (JP) 2012-02-08 CN disclosed
CN-101495571-A Thermoplastic resin composition and molded body thereof MITSUI CHEMICALS INC (JP) 2009-07-29 CN disclosed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP disclosed
US-20040220264-A1 Bioavailability and improved delivery of acidic pharmaceutical drugs YU RUEY J 2004-11-04 US disclosed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO disclosed
US-20030018100-A1 Inks with sulfonated polyester-amine resins XEROX CORPORATION. 2003-01-23 US disclosed
US-6432601-B1 DRY TONER INK XEROX CORPORATION 2002-08-13 US disclosed
US-6348561-B1 COPOLYMER FROM DIOL, DIACID, ALKALI SULFONATED DIACID AND AMINODIACID MONOMERS; TONERS, INKS, DISPERSANTS; HEAT AND COLD RESISTANCE; SHELF LIFE XEROX CORPORATION 2002-02-19 US disclosed
US-4165329-A CARBOXYLATED UREA METAL SALTS CHEVRON RESEARCH COMPANY (US) 1979-08-21 US disclosed